Next Generation News and Research

RSS

Study finds way to reverse gene silencing in inner ear cells

A deafened adult cannot recover the ability to hear, because the sensory hearing cells of the inner ear don't regenerate after damage.

14 Aug 2023

Study examines the relationship between consumption of fatty acids and diabetic retinopathy

Researchers examined the relationship between dietary fatty acid (FA) intake and diabetic retinopathy (DR).

14 Aug 2023

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Four major clinical trial networks based in low resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative to enhance clinical research in low resource settings.

10 Aug 2023

Optilume BPH Catheter System offers a safe and effective treatment for benign prostatic hyperplasia

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a randomized trial in the September issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA).

10 Aug 2023

Preventing the next pandemic: swine influenza genomic surveillance essential, study shows

Researchers explored the evolutionary dynamics of swine influenza A virus (swIAV) populations in Asia's southern and eastern regions.

10 Aug 2023

Study explores the diverse expression patterns of T cell priming markers across cancers

A recent study explored transcriptomics of T-cell priming markers (TPMs) across different cancers.

10 Aug 2023

MaxCyte signs strategic platform license with Lyell Immunopharma

From MaxCyte, Inc. 10 Aug 2023

MaxCyte and Vittoria Biotherapeutics sign strategic platform license to advance next generation cellular therapies

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, and Vittoria Biotherapeutics (Vittoria), a leading edge, gene-edited cell therapeutics company with novel platform technologies poised to develop a pipeline of highly differentiated cellular therapies for both oncology and immunology indications, today announced the signing of a strategic platform license (SPL) of MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to Vittoria Biotherapeutics.

From MaxCyte, Inc. 10 Aug 2023

MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients

From MaxCyte, Inc. 10 Aug 2023

Mice lacking TMCO3 gene have shortened bones

Through next-generation sequencing, investigators have identified a mutation in the TMCO3 gene in two sisters with short stature.

9 Aug 2023

New treatment approach shows promise in reversing hormone resistance in breast cancer

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively.

9 Aug 2023

UArizona Cancer Center receives $1.5 million grant for cancer prevention and control training

University of Arizona Cancer Center researchers were awarded a $1.5 million grant from the National Cancer Institute to deliver an intensive, multidisciplinary cancer prevention and control research training program for undergraduate and graduate students.

8 Aug 2023

Nationwide Children's Hospital pioneers new gene therapy for Duchenne muscular dystrophy

In a landmark moment for the Abigail Wexner Research Institute at Nationwide Children's, a 5-year-old from Bellefontaine, Ohio, received the first dose of a recently approved gene therapy for Duchenne muscular dystrophy at Nationwide Children's Hospital, where the therapy was invented and initially tested.

8 Aug 2023

Virginia Tech engages in three collaborative bioscience projects to address unmet health care needs

With funding from Virginia Catalyst, also known as the Virginia Biosciences Health Research Corp., Virginia Tech is engaged in three collaborative bioscience projects to address unmet health care needs in Virginia, according to Michael Friedlander, vice president for health sciences and technology at Virginia Tech.

8 Aug 2023

Self-organization of neurons explained using a mathematical theory

An international collaboration between researchers at the RIKEN Center for Brain Science (CBS) in Japan, the University of Tokyo, and University College London has demonstrated that self-organization of neurons as they "learn" follows a mathematical theory called the free energy principle.

8 Aug 2023

Next Generation News and Research

Study finds way to reverse gene silencing in inner ear cells

Study examines the relationship between consumption of fatty acids and diabetic retinopathy

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Optilume BPH Catheter System offers a safe and effective treatment for benign prostatic hyperplasia

Preventing the next pandemic: swine influenza genomic surveillance essential, study shows

Study explores the diverse expression patterns of T cell priming markers across cancers

MaxCyte signs strategic platform license with Lyell Immunopharma

MaxCyte and Vittoria Biotherapeutics sign strategic platform license to advance next generation cellular therapies

MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients

Mice lacking TMCO3 gene have shortened bones

New treatment approach shows promise in reversing hormone resistance in breast cancer

UArizona Cancer Center receives $1.5 million grant for cancer prevention and control training

Nationwide Children's Hospital pioneers new gene therapy for Duchenne muscular dystrophy

Virginia Tech engages in three collaborative bioscience projects to address unmet health care needs

Self-organization of neurons explained using a mathematical theory

Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

The green tea effect: From gut microbes to weight loss, new insights emerge

New antibody shows promise in reversing carfentanil overdoses

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

Similarities in gene expression between post-mortem and living human brains

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News